KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

Figure 5

Immunohistochemical analysis of BRAF mutated colorectal cancer with positive staining, ×50 HPF.